Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:00am, Thursday, 25'th Sep 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Declines More Than Market: Some Information for Investors
06:46pm, Tuesday, 23'rd Sep 2025
Novavax (NVAX) concluded the recent trading session at $8.68, signifying a -2.2% move from its prior day's close.
Mizuho's Jared Holz: There's not much value left in vaccine stocks
11:40am, Friday, 19'th Sep 2025
Jared Holz, Mizuho healthcare senior strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on pharmaceuticals, what new government vaccine panel recommendations mean for the stocks, and
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
01:49pm, Thursday, 18'th Sep 2025
The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters from Pfizer, Moderna and Novavax.
Here's Why Novavax (NVAX) Fell More Than Broader Market
06:46pm, Wednesday, 17'th Sep 2025
Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 10'th Sep 2025
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript
02:10pm, Thursday, 04'th Sep 2025
Novavax, Inc. (NASDAQ:NVAX ) Cantor Global Healthcare Conference 2025 September 4, 2025 10:20 AM EDT Company Participants John Jacobs - President, CEO & Director Ruxandra Draghia-Akli - Executive VP a
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
08:00am, Thursday, 04'th Sep 2025
GAITHERSBURG, Md. , Sept. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's COVID-19 vacci
FDA Approves Updated COVID-19 Vaccines but With Restrictions
01:06pm, Thursday, 28'th Aug 2025
FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term
10:50am, Thursday, 28'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
03:07pm, Wednesday, 27'th Aug 2025
Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season GAITHERSBURG, Md. , Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NV
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 27'th Aug 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax Announces Convertible Debt Refinancing
07:43am, Thursday, 21'st Aug 2025
Refinancing extends maturity of most existing debt with improved terms $225 million of convertible notes due in 2031 issued, including a ~$175 million exchange for the retirement of existing convertib
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Wednesday, 13'th Aug 2025
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
12:16pm, Thursday, 07'th Aug 2025
Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.
